For the uninitiated, LUMAS (Lung Maurity and Antenatal Steroids) was a prospective, randomized controlled trial that was performed at Barnes-Jewish Hospital. The study looked at the effects of steroids after 34 weeks in patients with a NEGATIVE TDX-FLMII for fetal lung maturity.
Residents had an active hand in recruiting patients and the results are available in this month's AJOG.
In case reading isn't your cup of tea (and it really should be) here is Reuter's video version of the study.
Thanks to recent graduate John Hoff for pointing this out.
Cool! Too bad the manufacturer is stopping production of the machine for the TDX-FLM method next year. Any ideas of what we will use next for testing FLM? What will be the next gold standard?
ReplyDeleteLamellar bodies. You can already send that but we will make the move together.
ReplyDelete